Go to main content

Pharmaceuticals and treatment

​Treatment effects demonstrated in studies conducted under controlled conditions must also be evident in the real world, where patients differ from one another and often live with multiple health conditions simultaneously.

For this reason, CCRP conducts broad research into medicines and treatments as they are used in everyday clinical practice. We generate knowledge about the effectiveness and safety of medicines, the appropriate use of pharmaceuticals, and the health economic aspects of medication use. We also investigate treatment-related adverse effects, inequalities in access to and outcomes of treatment, and the relationship between treatment and other factors such as education and employment.

Our work draws on the centre's extensive expertise in the Danish health registries. We specialize in integrating data from multiple sources, generating knowledge from these data, and transferring software solutions and methodological expertise from one medical field to another. This systematic approach has been developed within our Copenhagen Phase IV Unit.

Within the field of psychiatry, our research groups study a wide range of topics, including the prevalence, effectiveness, and dependency-related aspects of treatments for depression; electroconvulsive therapy (ECT); the impact of genetic and environmental factors on depression; and socioeconomic inequalities in mortality among patients with depression. We also have a research group dedicated to alcohol-related diseases.

We conduct literature reviews, register-based studies and studies using data from population surveys and patient health records. We also carry out questionnaire-based research and intervention studies, covering the entire research continuum from identifying unmet medical needs to conducting randomised clinical trials, as well as evaluating the effectiveness and safety of medicines after market approval and studying the implementation of treatments in clinical practice.

We collaborate with and provide expertise to stakeholders including the pharmaceutical industry and regulatory authorities, clinical departments, national and international research groups, municipalities and regional authorities.

Last updated:
Responsible editor
Klik for at scrolle op eller ned p� siden G� til toppen af siden